EMEA-001523-PIP04-19-M01

Table of contents

Key facts

Invented name
Tremfya
Active substance
Guselkumab
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0399/2022
PIP number
EMEA-001523-PIP04-19-M01
Pharmaceutical form(s)
  • Solution for injection
  • Solution for injection in pre-filled syringe
  • Solution for injection in pre-filled pen
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
  • Intravenous use
  • Subcutaneous use
Contact for public enquiries
Janssen-Cilag International N.V.

Tel. +32 14602111
E-mail: contact@Janssen-emea.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating